secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001628280-24-045687
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics files investor presentation for November 2024 with no material new disclosures
--------------------------------------------------------------------------------

- Furnished an investor presentation dated November 2024 under Item 7.01 Regulation FD.
- Presentation includes corporate overview; no specific financial or operational updates provided.
- No new guidance, product announcements, or changes in strategy disclosed in the exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024045687/0001628280-24-045687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024045687/aqst-20241106.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-045687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer